my question then is...
would using another anthracycline make things worse if in fact this was true for someone? I'm wondering if this isn't what happened in my case and my onc sees epirubicin in the future. I have maintained to her for several years that the A/C and radiation made no difference in my case and she is not sure. But since I recurred exactly where I'd been radiated and then we discovered a liver full of mets all within 2 years of stage I treatment I feel that I'm right on this (I feel I'm right on a lot of things, though ). SO my gut says to proceed with caution with anthracyclines.
Any thoughts from any of you really smart folks out there?
__________________
with love and gratitude,
joy
dx stage I 2/2000*er/pr+; her- per IHC*lumpectomy*4 rounds A/C*30 rads*tamoxifen*dx stage 4 5/2002*huge mets to liver*tiny mets to lungs*stopped tamoxifen*5/02 taxotere/xeloda*her 2 checked with FiSH-her2+++herceptin *2/03 stopped chemo femara w/herceptin*zolodex*04 switched to aromasin w/herceptin*05 high estrogen tx*11/05taxol/carbo*7/06 stopped chemo; megace/herceptin*9/06navelbine/herceptin*5/07tykerb/xeloda great response*4/08 progression in liver; ooph/ faslodex /herceptin
6/08 began Herceptin DM-1
9/08 progression
|